Skin Cancer Diagnosis and Therapeutics Market Trends, Size, Competitive Analysis and Forecast 2021-2027
The global skin cancer diagnosis and therapeutics market are anticipated to grow at a considerable CAGR of around 7.5% during the forecast period (2021-2027). One of the major drivers of the market is the increasing demand for skin cancer therapies such as radiation therapy, chemotherapy, immunotherapy, and other drug therapy. There has been an increased adoption rate of these therapeutics among the patients, which is likely to increase the market growth. According to WHO, the rate of both non-melanoma and melanoma skin cancers has been increasing day by day. Around 3 million non-melanoma skin cancers, and 132,000 melanoma skin cancers occur across the globe. In addition to that, several government initiatives have proven to be favorable for the skin cancer diagnosis and therapeutics market. Besides, there is a lack of awareness among the patients in emerging countries about the availability of this form of treatment is a restraint of the market.
To Request a Sample of our Report on Skin Cancer Diagnosis and Therapeutics Market: https://www.omrglobal.com/request-sample/skin-cancer-diagnosis-and-therapeutics-market
In addition, to create opportunities the key players operating in the market have been inventing new drugs with FDA approval of several new immunotherapies. For instance, In June 2020, Merck & Co., Inc. received approval for pembrolizumab for cutaneous squamous cell carcinoma from the US Food and Drug Administration (FDA). The drug is used for the treatment of a patient having metastatic cutaneous squamous cell carcinoma (CSCC) that is not treatable by surgery or radiation.
·
The market
number available for – 2020-2027
·
Base year-
2020
·
Forecast
period- 2021-2027
·
Segment
Covered-
·
By Type
·
By Therapy
·
ByDiagnosis
·
Regions
Covered-
·
North
America
·
Europe
·
Asia-Pacific
·
Rest of
the World
·
Competitive
Landscape – Pfizer Inc., Merck & co. Inc., Bristol Myers Squibb co.,
Novartis International AG, Sanofi S.A., Bausch Health Companies Inc., and
others
A
full Report of Skin Cancer Diagnosis and Therapeutics Market is Available
at: https://www.omrglobal.com/industry-reports/skin-cancer-diagnosis-and-therapeutics-market
Global Skin Cancer Diagnosis and Therapeutics
Market
By Type
·
Melanoma
·
Non-Melanoma
By Therapy
·
Surgery
treatment
·
Radiotherapy
·
Chemotherapy
·
Targeted
therapy
·
Immunotherapy
·
Others
By Diagnosis
·
Dermatoscopy
·
Biopsy
·
Blood test
·
X-rays
·
Others
Global Skin Cancer Diagnosis and Therapeutics
Market by Region
North
America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the
World
·
Latin America
·
Middle East & Africa
Company
Profiles
·
Agilent technologies
·
Amgen, Inc.
·
Aqua pharmaceuticals LLC
·
AstraZeneca PLC
·
Bausch Health Companies Inc.
·
Bristol Myers Squibb co.
·
Daiichi Sankyo Co. Ltd.
·
Elekta AB
·
Eli Lilly and Co.
·
Glaxosmithkline PLC
·
F. Hoffmann-La Roche Ltd.
·
IcadInc.
·
Merck & co. Inc.
·
Mylan N.V.
Reasons to buy from us –
1.
We cover more than 15 major industries, further segmented into more than
90 sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/skin-cancer-diagnosis-and-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment